Literature DB >> 19819946

Local secretion of urocortin 1 promotes microvascular permeability during lipopolysaccharide-induced inflammation.

Elizabeth L Cureton1, Alexander Q Ereso, Gregory P Victorino, Brian Curran, Daniel P Poole, Min Liao, Alden H Harken, Aditi Bhargava.   

Abstract

Urocortin 1 (Ucn1) is a neuropeptide that regulates vascular tone and is implicated in both the vascular and immune cell-mediated responses to inflammation. The role of Ucn1 in regulating microvascular permeability has not been determined. We hypothesized that local Ucn1 release promotes microvascular permeability and that this effect augments the local gastrointestinal vascular response to lipopolysaccharide (LPS)-induced systemic inflammation. We measured hydraulic (L(p)) and macromolecule permeability in mesenteric venules. We show that a continuous infusion of 10(-7) m Ucn1 in a postcapillary venule increased L(p) 2-fold over baseline, as did LPS-induced inflammation. However, simultaneous infusion of Ucn1 and LPS markedly increased L(p) by 7-fold. After local knockdown of Ucn1 using RNA interference, infusion of Ucn1 with LPS resulted in return to 2-fold increase, confirming that Ucn1 synergistically augments hydraulic permeability during inflammation. LPS and Ucn1 treatment also resulted in increased numbers of interstitial microspheres, which colocalized with CD31(+) immune cells. Ucn1 activity is mediated through two receptor subtypes, CRH-R(1) and CRH-R(2). CRH-R(1) receptor blockade exacerbated, whereas CRH-R(2) receptor blockade decreased the LPS-induced increase in L(p). Finally, treatment with the c-JUN N-terminal kinase (JNK) antagonist SP600125 during infusion of LPS, but not Ucn1, decreased L(p). These findings suggest that Ucn1 increases microvascular permeability and acts synergistically with LPS to increase fluid and macromolecule losses during inflammation. Knockdown of endogenous Ucn1 during inflammation attenuates synergistic increases in L(p). Ucn1's effect on L(p) is partially mediated by the CRH-R(2) receptor and acts independently of the c-JUN N-terminal kinase signal transduction pathway.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19819946      PMCID: PMC2795720          DOI: 10.1210/en.2009-0489

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  44 in total

Review 1.  Abdominal compartment syndrome.

Authors:  B H Saggi; H J Sugerman; R R Ivatury; G L Bloomfield
Journal:  J Trauma       Date:  1998-09

Review 2.  The NF-kappa B and I kappa B proteins: new discoveries and insights.

Authors:  A S Baldwin
Journal:  Annu Rev Immunol       Date:  1996       Impact factor: 28.527

Review 3.  Recent advances with the CRF1 receptor: design of small molecule inhibitors, receptor subtypes and clinical indications.

Authors:  J R McCarthy; S C Heinrichs; D E Grigoriadis
Journal:  Curr Pharm Des       Date:  1999-05       Impact factor: 3.116

Review 4.  Structure, regulation and function of NF-kappa B.

Authors:  U Siebenlist; G Franzoso; K Brown
Journal:  Annu Rev Cell Biol       Date:  1994

5.  A human homologue of the Drosophila Toll protein signals activation of adaptive immunity.

Authors:  R Medzhitov; P Preston-Hurlburt; C A Janeway
Journal:  Nature       Date:  1997-07-24       Impact factor: 49.962

6.  The complications of trauma and their associated costs in a level I trauma center.

Authors:  G E O'Keefe; R V Maier; P Diehr; D Grossman; G J Jurkovich; D Conrad
Journal:  Arch Surg       Date:  1997-08

7.  Potent mast cell degranulation and vascular permeability triggered by urocortin through activation of corticotropin-releasing hormone receptors.

Authors:  L K Singh; W Boucher; X Pang; R Letourneau; D Seretakis; M Green; T C Theoharides
Journal:  J Pharmacol Exp Ther       Date:  1999-03       Impact factor: 4.030

8.  The measurement of permeability in single rat venules using the red cell microperfusion technique.

Authors:  S Kendall; C C Michel
Journal:  Exp Physiol       Date:  1995-05       Impact factor: 2.969

9.  Corticosteroid-independent inhibition of tumor necrosis factor production by the neuropeptide urocortin.

Authors:  D Agnello; R Bertini; S Sacco; C Meazza; P Villa; P Ghezzi
Journal:  Am J Physiol       Date:  1998-11

10.  Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4)

Authors:  S T Qureshi; L Larivière; G Leveque; S Clermont; K J Moore; P Gros; D Malo
Journal:  J Exp Med       Date:  1999-02-15       Impact factor: 14.307

View more
  14 in total

1.  Sex- and corticotropin-releasing factor receptor 2- dependent actions of urocortin 1 during inflammation.

Authors:  Burcu Hasdemir; Pallavi Mhaske; Sreenivasan Paruthiyil; Elizabeth A Garnett; Melvin B Heyman; Mehrdad Matloubian; Aditi Bhargava
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-04-06       Impact factor: 3.619

2.  Corticotropin-releasing factor receptor 2 mediates sex-specific cellular stress responses.

Authors:  Eric Kubat; Shilpi Mahajan; Min Liao; Larry Ackerman; Peter T Ohara; Eileen F Grady; Aditi Bhargava
Journal:  Mol Med       Date:  2013-07-24       Impact factor: 6.354

3.  Attenuation of endothelial phosphatidylserine exposure decreases ischemia-reperfusion induced changes in microvascular permeability.

Authors:  Aaron Strumwasser; Aditi Bhargava; Gregory P Victorino
Journal:  J Trauma Acute Care Surg       Date:  2018-06       Impact factor: 3.313

4.  Urocortin 1 modulates immunosignaling in a rat model of colitis via corticotropin-releasing factor receptor 2.

Authors:  Jen Chang; Melanie R Adams; Matthew S Clifton; Min Liao; Julia H Brooks; Burcu Hasdemir; Aditi Bhargava
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-02-17       Impact factor: 4.052

5.  Evidence for CRHR1 in multiple sclerosis using supervised machine learning and meta-analysis in 12,566 individuals.

Authors:  Farren B S Briggs; Selena E Bartlett; Benjamin A Goldstein; Joanne Wang; Jacob L McCauley; Rebecca L Zuvich; Philip L De Jager; John D Rioux; Adrian J Ivinson; Alastair Compston; David A Hafler; Stephen L Hauser; Jorge R Oksenberg; Stephen J Sawcer; Margaret A Pericak-Vance; Jonathan L Haines; Lisa F Barcellos
Journal:  Hum Mol Genet       Date:  2010-08-10       Impact factor: 6.150

Review 6.  Corticotropin-releasing factor family and its receptors: pro-inflammatory or anti-inflammatory targets in the periphery?

Authors:  Huayuan Zhu; Juejin Wang; Jianyong Li; Shengnan Li
Journal:  Inflamm Res       Date:  2011-04-08       Impact factor: 4.575

7.  Urocortin 3 expression at baseline and during inflammation in the colon: corticotropin releasing factor receptors cross-talk.

Authors:  Shilpi Mahajan; Min Liao; Paris Barkan; Kazuhiro Takahashi; Aditi Bhargava
Journal:  Peptides       Date:  2014-01-22       Impact factor: 3.750

8.  Systemic administration of urocortin after intracerebral hemorrhage reduces neurological deficits and neuroinflammation in rats.

Authors:  Hock-Kean Liew; Cheng-Yoong Pang; Chih-Wei Hsu; Mei-Jen Wang; Ting-Yi Li; Hsiao-Fen Peng; Jon-Son Kuo; Jia-Yi Wang
Journal:  J Neuroinflammation       Date:  2012-01-19       Impact factor: 8.322

9.  Vasoprotective effects of urocortin 1 against atherosclerosis in vitro and in vivo.

Authors:  Akinori Hasegawa; Kengo Sato; Remina Shirai; Rena Watanabe; Keigo Yamamoto; Kaho Watanabe; Kyoko Nohtomi; Tsutomu Hirano; Takuya Watanabe
Journal:  PLoS One       Date:  2014-12-02       Impact factor: 3.240

10.  Role of Corticotropin-releasing Factor in Gastrointestinal Permeability.

Authors:  Bruno K Rodiño-Janeiro; Carmen Alonso-Cotoner; Marc Pigrau; Beatriz Lobo; María Vicario; Javier Santos
Journal:  J Neurogastroenterol Motil       Date:  2015-01-01       Impact factor: 4.924

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.